These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 15933632

  • 1. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
    Matsuda T, Freeman TA, Hilbert DW, Duff M, Fuortes M, Stapleton PP, Daly JM.
    Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632
    [Abstract] [Full Text] [Related]

  • 2. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J, Dofferhoff AS, Mouton JW, van der Meer JW.
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [Abstract] [Full Text] [Related]

  • 3. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
    Vianna RC, Gomes RN, Bozza FA, Amâncio RT, Bozza PT, David CM, Castro-Faria-Neto HC.
    Shock; 2004 Feb; 21(2):115-20. PubMed ID: 14752283
    [Abstract] [Full Text] [Related]

  • 4. Peritonitis in childhood: clinical relevance of cytokines in the peritoneal exudate.
    Haecker FM, Fasler-Kan E, Manasse C, Fowler B, Hertel R, von Schweinitz D.
    Eur J Pediatr Surg; 2006 Apr; 16(2):94-9. PubMed ID: 16685614
    [Abstract] [Full Text] [Related]

  • 5. Induction of endotoxin tolerance with monophosphoryl lipid A in peritonitis: importance of localized therapy.
    Astiz ME, Saha DC, Carpati CM, Rackow EC.
    J Lab Clin Med; 1994 Jan; 123(1):89-93. PubMed ID: 8288966
    [Abstract] [Full Text] [Related]

  • 6. Endogenous IL-10 leads to impaired bacterial clearance and reduced survival in a murine model of chronic peritonitis.
    Lenz AM, Franklin GA, Fairweather M, McClintock ML, Jala VR, Peyton JC, Gardner SA, Cheadle WG.
    Cytokine; 2007 Dec; 40(3):207-15. PubMed ID: 18053738
    [Abstract] [Full Text] [Related]

  • 7. Early effects of laparotomy and laparoscopy on bacterial behavior and proinflammatory cytokines on bacterial peritonitis in rats I: Escherichia coli.
    Didem B, Hüseyin B, Osman Y, Yasemin B, Necati G, Canan T.
    J Pediatr Surg; 2008 Aug; 43(8):1494-501. PubMed ID: 18675641
    [Abstract] [Full Text] [Related]

  • 8. Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice.
    Brüggemann LW, Schoenmakers SH, Groot AP, Reitsma PH, Spek CA.
    Crit Care Med; 2006 Aug; 34(8):2201-6. PubMed ID: 16775574
    [Abstract] [Full Text] [Related]

  • 9. Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice.
    Buijs J, Dofferhoff AS, Mouton JW, van der Meer JW.
    Clin Microbiol Infect; 2006 Nov; 12(11):1105-11. PubMed ID: 17002610
    [Abstract] [Full Text] [Related]

  • 10. Urokinase-type plasminogen activator receptor plays a role in neutrophil migration during lipopolysaccharide-induced peritoneal inflammation but not during Escherichia coli-induced peritonitis.
    Renckens R, Roelofs JJ, Florquin S, van der Poll T.
    J Infect Dis; 2006 Feb 15; 193(4):522-30. PubMed ID: 16425131
    [Abstract] [Full Text] [Related]

  • 11. Mortality rate and bacteremia, endotoxin, and endothelin-1 levels in antibiotic therapy for E. coli septic peritonitis.
    Tsukada K, Katoh H, Shiojima M, Takenoshita S, Nagamachi Y.
    APMIS; 1993 Feb 15; 101(2):97-100. PubMed ID: 8489768
    [Abstract] [Full Text] [Related]

  • 12. Genetic background determines susceptibility during murine septic peritonitis.
    Godshall CJ, Scott MJ, Peyton JC, Gardner SA, Cheadle WG.
    J Surg Res; 2002 Jan 15; 102(1):45-9. PubMed ID: 11792151
    [Abstract] [Full Text] [Related]

  • 13. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels.
    Kumar A, Haery C, Paladugu B, Kumar A, Symeoneides S, Taiberg L, Osman J, Trenholme G, Opal SM, Goldfarb R, Parrillo JE.
    J Infect Dis; 2006 Jan 15; 193(2):251-8. PubMed ID: 16362889
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
    Giacometti A, Ghiselli R, Cirioni O, Mocchegiani F, D'Amato G, Orlando F, Sisti V, Kamysz W, Silvestri C, Naldoski P, Lukasiak J, Saba V, Scalise G.
    J Antimicrob Chemother; 2004 Sep 15; 54(3):654-60. PubMed ID: 15294887
    [Abstract] [Full Text] [Related]

  • 15. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.
    Lally KP, Cruz E, Xue H.
    J Pediatr Surg; 2000 Jun 15; 35(6):852-4; discussion 855. PubMed ID: 10873025
    [Abstract] [Full Text] [Related]

  • 16. Bile increases lipopolysaccharide release in experimental E. coli peritonitis.
    Andersson R, Sonesson A, Larsson L, Schalén C, Tranberg KG.
    Eur J Surg; 1991 Feb 15; 157(2):117-20. PubMed ID: 1676304
    [Abstract] [Full Text] [Related]

  • 17. Liver lipid peroxidation in experimental Escherichia coli peritonitis: the role of myeloperoxidase and nitric oxide inhibition.
    Demir M, Sert S, Kaleli I, Demir S, Cevahir N, Yildirim U, Sahin B.
    Med Sci Monit; 2007 Oct 15; 13(10):BR225-9. PubMed ID: 17901846
    [Abstract] [Full Text] [Related]

  • 18. IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance.
    Sewnath ME, Olszyna DP, Birjmohun R, ten Kate FJ, Gouma DJ, van Der Poll T.
    J Immunol; 2001 May 15; 166(10):6323-31. PubMed ID: 11342656
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.